About Authentidate (OTCMKTS:ADAT)
Authentidate Holding Corp. and its subsidiaries provide Web-based revenue cycle management applications, and telehealth products and services. The Company enables healthcare organizations to coordinate care for patients and to manage related administrative and clinical workflows. Its Web-based solutions incorporate multiple features and security technologies, such as business-rules based electronic forms, intelligent routing, transaction management, electronic signatures, identity credentialing, content authentication, automated audit trails and remote patient management capabilities. The Company's Inscrybe Healthcare is a Web-based revenue cycle management workflow automation solution. Its Telehealth Solutions provide an advanced in-home patient vital signs monitoring system and a Web-based management and monitoring software module for use by healthcare providers. The Company's AuthentiProof is a content integrity and time-and-date stamp application.
Industry, Sector and Symbol
Industry Healthcare Information Services
Trailing P/E Ratio-0.285266457680251
Forward P/E RatioN/A
Sales & Book Value
Annual Sales$20.19 million
Price / Sales0.33
Cash Flow$3.64 per share
Price / Cash0.25
Book Value$0.54 per share
Price / Book1.69
Return on Equity117.47%
Return on Assets73.24%
Authentidate (OTCMKTS:ADAT) Frequently Asked Questions
What is Authentidate's stock symbol?
Authentidate trades on the OTCMKTS under the ticker symbol "ADAT."
How were Authentidate's earnings last quarter?
Authentidate Holding Corp. (OTCMKTS:ADAT) issued its quarterly earnings results on Tuesday, September, 27th. The technology company reported ($0.03) earnings per share (EPS) for the quarter. The technology company earned $7.60 million during the quarter. Authentidate had a positive return on equity of 117.47% and a negative net margin of 198.40%. View Authentidate's Earnings History.
When will Authentidate make its next earnings announcement?
Who are some of Authentidate's key competitors?
Some companies that are related to Authentidate include Heat Biologics (HTBX), OpGen (OPGN), Apricus Biosciences (APRI), Acura Pharmaceuticals (ACUR), Neovasc Inc (US) (NVCN), Eyegate Pharmaceuticals (EYEG), Neurometrix (NURO), Windtree Therapeutics (WINT), SenesTech (SNES), Alliqua Biomedical (ALQA), Auris Medical (EARS), Anthera Pharmaceuticals (ANTH), Bioblast Pharma (ORPN), Argos Therapeutics (ARGS), Sunshine Heart (CHFS), Precipio (PRPO), Immune Pharmaceuticals (IMNP) and Mateon Therapeutics (MATN).
Who are Authentidate's key executives?
Authentidate's management team includes the folowing people:
- Hanif A. Roshan, Chairman of the Board, Chief Executive Officer
- J. David Luce, Vice Chairman of the Board (Age 54)
- Michael J. Poelking, Chief Financial Officer, Treasurer (Age 61)
- David C. Goldberg, Chief Operating Officer (Age 60)
- Mustafa Chagani, Director (Age 51)
- Richard Hersperger, Director
- Varinder Singh Rathore, Director (Age 44)
- Todd A. Borus M.D., Independent Director (Age 41)
- Marc A. Horowitz, Independent Director (Age 57)
Has Authentidate been receiving favorable news coverage?
News coverage about ADAT stock has trended somewhat positive recently, Accern Sentiment reports. Accern ranks the sentiment of news coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Authentidate earned a news sentiment score of 0.17 on Accern's scale. They also assigned media headlines about the technology company an impact score of 45.79 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next few days.
How do I buy shares of Authentidate?
Shares of ADAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Authentidate's stock price today?
One share of ADAT stock can currently be purchased for approximately $0.91.
How big of a company is Authentidate?
Authentidate has a market capitalization of $6.31 million and generates $20.19 million in revenue each year. The technology company earns $-32,070,000.00 in net income (profit) each year or ($3.19) on an earnings per share basis. Authentidate employs 83 workers across the globe.
How can I contact Authentidate?
Authentidate's mailing address is 2225 Centennial Dr, GAINESVILLE, GA 30504-5760, United States. The technology company can be reached via phone at +1-908-7871700.
MarketBeat Community Rating for Authentidate (ADAT)MarketBeat's community ratings are surveys of what our community members think about Authentidate and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Authentidate (OTCMKTS:ADAT) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Authentidate (OTCMKTS:ADAT) Earnings History and Estimates Chart
Authentidate (OTCMKTS ADAT) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|6/26/2018|| || || || || || || || |
|7/28/2017||Q3 2017||$0.04||$5.53 million||View||N/A|
|6/23/2017||Q1 2017||($0.03)||$6.05 million||View||N/A|
|4/5/2017||Q4 2016||($2.04)||$4.36 million||View||N/A|
|2/22/2016||Q415||($1.32)||$1.35 million||$0.40 million||View||N/A|
|11/13/2015||Q1 2016||($0.45)||$0.40 million||View||N/A|
|10/13/2015||Q4 2015||($0.72)||$0.52 million||View||N/A|
|5/20/2015||Q315||($0.06)||$1.22 million||$0.77 million||View||Listen|
|2/17/2015||Q2 2015||($0.45)||$1.35 million||View||N/A|
|11/13/2014||Q1 2015||($0.54)||$1.05 million||View||N/A|
|5/15/2014||Q3 2014||($0.36)||$1.22 million||View||N/A|
|2/13/2014||Q2 2014||($0.63)||$1.46 million||View||N/A|
|11/14/2013||Q1 2014||($0.81)||$1.81 million||View||N/A|
|9/26/2013||Q413||($0.12)||$1.00 million||$1.40 million||View||N/A|
|5/15/2013||Q3 2013||($0.99)||$1.41 million||View||N/A|
Authentidate (OTCMKTS:ADAT) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Authentidate (OTCMKTS:ADAT)
No dividend announcements for this company have been tracked by MarketBeat.com
Authentidate (OTCMKTS ADAT) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 6.50%
Authentidate (OTCMKTS ADAT) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|11/17/2017||David C Goldberg||COO||Buy||2,000||$0.55||$1,100.00|| |
|10/14/2016||Lazarus Management Co Llc||Major Shareholder||Sell||320,000||$3.25||$1,040,000.00|| |
|8/29/2014||Lazarus Investment Partners Ll||Major Shareholder||Buy||704,225||$0.71||$499,999.75|| |
|6/13/2014||Charles C Lucas III||Director||Buy||5,000||$0.69||$3,450.00|| |
|8/10/2012||Lazarus Investment Partners Ll||Major Shareholder||Buy||1,123||$0.74||$831.02|| |
Authentidate (OTCMKTS ADAT) News Headlines
Authentidate (OTCMKTS:ADAT) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Authentidate (OTCMKTS:ADAT) Income Statement, Balance Sheet and Cash Flow Statement
Authentidate (OTCMKTS ADAT) Stock Chart for Tuesday, March, 20, 2018